Screener
Nektar Therapeutics NKTR Business Segments — Segment Reporting Other Item Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Employee costs (a) | 13,678 | 11,974 |
| Facilities costs | 2,833 | 3,358 |
| Other operating costs (b) | 7,702 | 17,260 |
| Other segment expenses | 4,272 | 4,461 |
| Total operating costs and expenses | 49,915 | 54,995 |
| Loss from operations | (39,054) | (44,535) |
| Non-operating income (expense): | ||
| Non-cash interest expense on liability related to sale of future royalties | (7,942) | (4,974) |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's business segments — segment reporting other item amount?
- Nektar Therapeutics (NKTR) reported business segments — segment reporting other item amount of $4.27M in Q1 2026.
- How has Nektar Therapeutics's business segments — segment reporting other item amount changed year-over-year?
- Nektar Therapeutics's business segments — segment reporting other item amount decreased by 4.2% year-over-year, from $4.46M to $4.27M.
- What is the long-term trend for Nektar Therapeutics's business segments — segment reporting other item amount?
- Over 2 years (2023 to 2025), Nektar Therapeutics's business segments — segment reporting other item amount has grown at a -60.9% compound annual growth rate (CAGR), from $149.34M to $22.88M.
- What does business segments — segment reporting other item amount mean?
- Captures miscellaneous or non-recurring financial items that are allocated to the segment but do not fit into standard operating expense categories. This metric provides visibility into unique operational adjustments or incidental costs that impact the segment's overall profitability. Investors use this to identify irregular charges that may distort underlying segment performance.
Ask your AI about Nektar Therapeutics's business segments — segment reporting other item amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude